Sarcopenia Impacts on Short- and Long-term Results of Hepatectomy for Hepatocellular Carcinoma

To evaluate the prevalence of sarcopenia among European patients with resectable hepatocellular carcinoma (HCC) and to assess its prognostic impact on overall and disease-free survival. Identification of preoperative prognostic factors in liver surgery for HCC is required to better select patients a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of surgery Jg. 261; H. 6; S. 1173
Hauptverfasser: Voron, Thibault, Tselikas, Lambros, Pietrasz, Daniel, Pigneur, Frederic, Laurent, Alexis, Compagnon, Philippe, Salloum, Chady, Luciani, Alain, Azoulay, Daniel
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 01.06.2015
Schlagworte:
ISSN:1528-1140, 1528-1140
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract To evaluate the prevalence of sarcopenia among European patients with resectable hepatocellular carcinoma (HCC) and to assess its prognostic impact on overall and disease-free survival. Identification of preoperative prognostic factors in liver surgery for HCC is required to better select patients and improve survival. Recent studies have shown that preoperative discrimination of patients with low skeletal muscle mass (sarcopenic patients) using computed tomography was associated with morbidity and mortality after liver and colorectal surgery. Assessment of sarcopenia could be used to evaluate patients before hepatectomy for HCC. All consecutive patients who underwent hepatectomy for HCC in our institution, between February 2006 and September 2012, were included. Univariate and multivariate analyses evaluating prognostic factors of postoperative mortality and cancer recurrence were performed, including preoperative, surgical, and histopathological factors. Among 198 patients who underwent hepatectomy for HCC, 109 patients had an available computed tomographic scan and represent the study cohort. After a median follow-up of 21.23 months, 27 patients (24.8%) died. There were 20 deaths among the 59 patients who had sarcopenia and only 7 deaths in the nonsarcopenic group. Sarcopenic patients had significantly shorter median overall survival than nonsarcopenic patients (52.3 months vs 70.3 months; P = 0.015). On multivariate analysis, sarcopenia was found to be an independent predictor of poor overall survival (hazard ratio = 3.19; P = 0.013) and disease-free survival (hazard ratio = 2.60; P = 0.001). Sarcopenia was found to be a strong and independent prognostic factor for mortality after hepatectomy for HCC in European patients and could be used to evaluate eligibility of patients with HCC before surgery.
AbstractList To evaluate the prevalence of sarcopenia among European patients with resectable hepatocellular carcinoma (HCC) and to assess its prognostic impact on overall and disease-free survival. Identification of preoperative prognostic factors in liver surgery for HCC is required to better select patients and improve survival. Recent studies have shown that preoperative discrimination of patients with low skeletal muscle mass (sarcopenic patients) using computed tomography was associated with morbidity and mortality after liver and colorectal surgery. Assessment of sarcopenia could be used to evaluate patients before hepatectomy for HCC. All consecutive patients who underwent hepatectomy for HCC in our institution, between February 2006 and September 2012, were included. Univariate and multivariate analyses evaluating prognostic factors of postoperative mortality and cancer recurrence were performed, including preoperative, surgical, and histopathological factors. Among 198 patients who underwent hepatectomy for HCC, 109 patients had an available computed tomographic scan and represent the study cohort. After a median follow-up of 21.23 months, 27 patients (24.8%) died. There were 20 deaths among the 59 patients who had sarcopenia and only 7 deaths in the nonsarcopenic group. Sarcopenic patients had significantly shorter median overall survival than nonsarcopenic patients (52.3 months vs 70.3 months; P = 0.015). On multivariate analysis, sarcopenia was found to be an independent predictor of poor overall survival (hazard ratio = 3.19; P = 0.013) and disease-free survival (hazard ratio = 2.60; P = 0.001). Sarcopenia was found to be a strong and independent prognostic factor for mortality after hepatectomy for HCC in European patients and could be used to evaluate eligibility of patients with HCC before surgery.
To evaluate the prevalence of sarcopenia among European patients with resectable hepatocellular carcinoma (HCC) and to assess its prognostic impact on overall and disease-free survival.OBJECTIVETo evaluate the prevalence of sarcopenia among European patients with resectable hepatocellular carcinoma (HCC) and to assess its prognostic impact on overall and disease-free survival.Identification of preoperative prognostic factors in liver surgery for HCC is required to better select patients and improve survival. Recent studies have shown that preoperative discrimination of patients with low skeletal muscle mass (sarcopenic patients) using computed tomography was associated with morbidity and mortality after liver and colorectal surgery. Assessment of sarcopenia could be used to evaluate patients before hepatectomy for HCC.BACKGROUNDIdentification of preoperative prognostic factors in liver surgery for HCC is required to better select patients and improve survival. Recent studies have shown that preoperative discrimination of patients with low skeletal muscle mass (sarcopenic patients) using computed tomography was associated with morbidity and mortality after liver and colorectal surgery. Assessment of sarcopenia could be used to evaluate patients before hepatectomy for HCC.All consecutive patients who underwent hepatectomy for HCC in our institution, between February 2006 and September 2012, were included. Univariate and multivariate analyses evaluating prognostic factors of postoperative mortality and cancer recurrence were performed, including preoperative, surgical, and histopathological factors.METHODSAll consecutive patients who underwent hepatectomy for HCC in our institution, between February 2006 and September 2012, were included. Univariate and multivariate analyses evaluating prognostic factors of postoperative mortality and cancer recurrence were performed, including preoperative, surgical, and histopathological factors.Among 198 patients who underwent hepatectomy for HCC, 109 patients had an available computed tomographic scan and represent the study cohort. After a median follow-up of 21.23 months, 27 patients (24.8%) died. There were 20 deaths among the 59 patients who had sarcopenia and only 7 deaths in the nonsarcopenic group. Sarcopenic patients had significantly shorter median overall survival than nonsarcopenic patients (52.3 months vs 70.3 months; P = 0.015). On multivariate analysis, sarcopenia was found to be an independent predictor of poor overall survival (hazard ratio = 3.19; P = 0.013) and disease-free survival (hazard ratio = 2.60; P = 0.001).RESULTSAmong 198 patients who underwent hepatectomy for HCC, 109 patients had an available computed tomographic scan and represent the study cohort. After a median follow-up of 21.23 months, 27 patients (24.8%) died. There were 20 deaths among the 59 patients who had sarcopenia and only 7 deaths in the nonsarcopenic group. Sarcopenic patients had significantly shorter median overall survival than nonsarcopenic patients (52.3 months vs 70.3 months; P = 0.015). On multivariate analysis, sarcopenia was found to be an independent predictor of poor overall survival (hazard ratio = 3.19; P = 0.013) and disease-free survival (hazard ratio = 2.60; P = 0.001).Sarcopenia was found to be a strong and independent prognostic factor for mortality after hepatectomy for HCC in European patients and could be used to evaluate eligibility of patients with HCC before surgery.CONCLUSIONSSarcopenia was found to be a strong and independent prognostic factor for mortality after hepatectomy for HCC in European patients and could be used to evaluate eligibility of patients with HCC before surgery.
Author Tselikas, Lambros
Pietrasz, Daniel
Azoulay, Daniel
Laurent, Alexis
Voron, Thibault
Compagnon, Philippe
Salloum, Chady
Luciani, Alain
Pigneur, Frederic
Author_xml – sequence: 1
  givenname: Thibault
  surname: Voron
  fullname: Voron, Thibault
  organization: Departments of Digestive and Hepatobiliary Surgery †Radiology, Henri-Mondor Hospital, AP-HP, Créteil, France ‡Université Paris Est, Faculté de Médecine Créteil, Créteil, France; and §INSERM, U 955, Equipe 18, Creteil, F-94010, France
– sequence: 2
  givenname: Lambros
  surname: Tselikas
  fullname: Tselikas, Lambros
– sequence: 3
  givenname: Daniel
  surname: Pietrasz
  fullname: Pietrasz, Daniel
– sequence: 4
  givenname: Frederic
  surname: Pigneur
  fullname: Pigneur, Frederic
– sequence: 5
  givenname: Alexis
  surname: Laurent
  fullname: Laurent, Alexis
– sequence: 6
  givenname: Philippe
  surname: Compagnon
  fullname: Compagnon, Philippe
– sequence: 7
  givenname: Chady
  surname: Salloum
  fullname: Salloum, Chady
– sequence: 8
  givenname: Alain
  surname: Luciani
  fullname: Luciani, Alain
– sequence: 9
  givenname: Daniel
  surname: Azoulay
  fullname: Azoulay, Daniel
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24950264$$D View this record in MEDLINE/PubMed
BookMark eNpNUE1Lw0AUXKRiP_QfiOzRS-p-ZpNjKdYWAoLVq2GTvGgkuxt3k0P_vSmt0MfAm-ENw_DmaGKdBYTuKVlSkqqnfbZakstRgl-hGZUsiSgVZHLBp2gewg8hVCRE3aApE6kkLBYz9LnXvnQd2Ebjnel02QfsLN5_O99HWNsKZ85-RT14g98gDO3xXuMtdLqHsnfmgGvnT9qV0LZDqz1ej6GNdUbfoutatwHuznuBPjbP7-ttlL2-7NarLCq54n1UAOdSaVCxTqq4ZmWh2EiBca0kE7WQsgJV0IQTpWQSS0VpVdBUkLRghdBsgR5PuZ13vwOEPjdNONbRFtwQcqpIzEZIPlofztahMFDlnW-M9of8_yfsDxXeZXI
CitedBy_id crossref_primary_10_1016_j_jss_2016_12_014
crossref_primary_10_3390_life14081036
crossref_primary_10_1016_j_pan_2018_09_011
crossref_primary_10_1007_s11605_017_3580_1
crossref_primary_10_1080_17474124_2020_1757427
crossref_primary_10_1007_s10120_017_0722_9
crossref_primary_10_1016_j_nut_2021_111229
crossref_primary_10_1007_s00268_017_3909_7
crossref_primary_10_1016_j_ejso_2022_10_008
crossref_primary_10_3390_nu15051193
crossref_primary_10_1055_a_2189_6353
crossref_primary_10_1016_j_amjsurg_2018_10_039
crossref_primary_10_1007_s10147_021_01958_0
crossref_primary_10_1002_jpen_1792
crossref_primary_10_1017_S0029665115004279
crossref_primary_10_1007_s00268_015_3140_3
crossref_primary_10_1016_j_ajt_2022_11_016
crossref_primary_10_1016_j_dld_2024_12_003
crossref_primary_10_1186_s13741_016_0052_1
crossref_primary_10_1002_jcsm_12771
crossref_primary_10_1007_s00330_025_11349_y
crossref_primary_10_1097_TP_0000000000001587
crossref_primary_10_1002_jcsm_12529
crossref_primary_10_1007_s00432_023_05051_z
crossref_primary_10_1016_j_dld_2020_04_009
crossref_primary_10_1007_s11605_018_3695_z
crossref_primary_10_1016_j_jchirv_2015_06_006
crossref_primary_10_1007_s00423_024_03274_3
crossref_primary_10_1016_j_clnu_2020_05_038
crossref_primary_10_1055_s_0043_1764281
crossref_primary_10_1016_j_surg_2022_04_022
crossref_primary_10_20960_nh_05564
crossref_primary_10_1111_jgh_15026
crossref_primary_10_1007_s11605_020_04522_9
crossref_primary_10_2147_CMAR_S275307
crossref_primary_10_1007_s11695_018_3169_0
crossref_primary_10_1245_s10434_018_6354_4
crossref_primary_10_1007_s10388_019_00670_3
crossref_primary_10_1016_j_clnu_2018_12_025
crossref_primary_10_1177_0148607115612054
crossref_primary_10_1016_j_jviscsurg_2015_08_001
crossref_primary_10_1002_jcsm_13040
crossref_primary_10_1007_s11605_016_3146_7
crossref_primary_10_1002_ygh2_412
crossref_primary_10_1016_j_clnu_2017_06_028
crossref_primary_10_1186_s12876_020_01472_z
crossref_primary_10_1016_j_surge_2018_09_003
crossref_primary_10_1016_j_nut_2020_110798
crossref_primary_10_1371_journal_pone_0129742
crossref_primary_10_1002_jcsm_12995
crossref_primary_10_1111_aor_13962
crossref_primary_10_3390_diagnostics9040206
crossref_primary_10_1016_j_ejrad_2020_108889
crossref_primary_10_1097_MD_0000000000003164
crossref_primary_10_3390_jcm14176107
crossref_primary_10_3390_cancers16132315
crossref_primary_10_1016_j_surg_2020_03_005
crossref_primary_10_3389_fonc_2021_744311
crossref_primary_10_1016_S0985_0562_14_70895_7
crossref_primary_10_1016_j_clnu_2020_12_011
crossref_primary_10_3389_fnut_2023_1315097
crossref_primary_10_1007_s11605_018_3802_1
crossref_primary_10_1136_bmjopen_2019_034495
crossref_primary_10_1016_j_ejim_2022_07_002
crossref_primary_10_3390_jcm11113184
crossref_primary_10_1007_s00423_022_02541_5
crossref_primary_10_1016_j_jcrc_2017_12_027
crossref_primary_10_2147_JHC_S300680
crossref_primary_10_1007_s00423_020_01973_1
crossref_primary_10_1177_0884533616676264
crossref_primary_10_1097_JS9_0000000000001303
crossref_primary_10_1097_SLA_0000000000002679
crossref_primary_10_1097_SLA_0000000000002555
crossref_primary_10_1007_s10120_016_0683_4
crossref_primary_10_1146_annurev_nutr_082117_051723
crossref_primary_10_1111_jgh_14309
crossref_primary_10_1097_JS9_0000000000000688
crossref_primary_10_2147_JHC_S407646
crossref_primary_10_3389_fonc_2022_1007771
crossref_primary_10_1245_s10434_020_09147_5
crossref_primary_10_1590_s0004_2803_24612024_136
crossref_primary_10_1245_s10434_015_4887_3
crossref_primary_10_1038_s41598_022_27238_z
crossref_primary_10_4174_astr_2025_108_6_345
crossref_primary_10_1016_j_livres_2024_03_001
crossref_primary_10_1245_s10434_015_4763_1
crossref_primary_10_1016_j_asjsur_2022_07_122
crossref_primary_10_1007_s10029_024_03174_x
crossref_primary_10_3389_fnut_2022_878791
crossref_primary_10_1097_JS9_0000000000000458
crossref_primary_10_1177_00031348231160840
crossref_primary_10_2147_JHC_S418885
crossref_primary_10_1038_s41598_025_87458_x
crossref_primary_10_1016_j_jvir_2019_01_005
crossref_primary_10_1016_j_ejca_2015_12_030
crossref_primary_10_1080_17474124_2021_1912591
crossref_primary_10_3748_wjg_v28_i36_5324
crossref_primary_10_1007_s00268_015_2988_6
crossref_primary_10_1016_j_archger_2021_104534
crossref_primary_10_1080_01635581_2020_1750662
crossref_primary_10_1016_j_ejso_2024_108533
crossref_primary_10_3390_jcm11071860
crossref_primary_10_1016_j_gassur_2024_03_001
crossref_primary_10_1007_s00520_019_04767_4
crossref_primary_10_3390_cells10030516
crossref_primary_10_1016_j_asjsur_2021_09_012
crossref_primary_10_1016_j_surg_2019_03_020
crossref_primary_10_1016_j_surg_2016_08_030
crossref_primary_10_1186_s12957_021_02283_6
crossref_primary_10_1186_s12885_023_11251_0
crossref_primary_10_1016_j_clnu_2020_09_016
crossref_primary_10_1002_jpen_1696
crossref_primary_10_1002_jcsm_12274
crossref_primary_10_1002_jcsm_12276
crossref_primary_10_1080_01635581_2022_2117387
crossref_primary_10_1007_s00595_020_02225_x
crossref_primary_10_3892_mco_2018_1607
crossref_primary_10_2478_raon_2021_0004
crossref_primary_10_1007_s11605_019_04198_w
crossref_primary_10_1016_j_arr_2022_101739
crossref_primary_10_1007_s00423_017_1589_2
crossref_primary_10_1016_j_ejso_2020_09_002
crossref_primary_10_1016_j_clnesp_2019_06_003
crossref_primary_10_1016_j_nut_2018_10_025
crossref_primary_10_2147_CMAR_S305253
crossref_primary_10_3390_cancers16061080
crossref_primary_10_1055_a_2189_8567
crossref_primary_10_1016_j_nut_2021_111232
crossref_primary_10_3389_fnut_2022_978110
crossref_primary_10_1002_cam4_4448
crossref_primary_10_1002_ags3_12547
crossref_primary_10_1016_j_surge_2018_03_001
crossref_primary_10_1186_s12957_025_03765_7
crossref_primary_10_1007_s11605_018_3878_7
crossref_primary_10_3389_fonc_2019_01561
crossref_primary_10_1016_j_clnu_2018_09_019
crossref_primary_10_1016_j_pharmthera_2018_12_003
crossref_primary_10_1002_jcsm_12258
crossref_primary_10_1093_annonc_mdx271
crossref_primary_10_1007_s00268_016_3732_6
crossref_primary_10_3748_wjg_v28_i4_432
crossref_primary_10_1016_j_nut_2021_111184
crossref_primary_10_1038_s41598_022_21443_6
crossref_primary_10_1016_j_asjsur_2020_11_001
crossref_primary_10_3390_cancers13112708
crossref_primary_10_3390_cancers14030720
crossref_primary_10_1016_j_surg_2022_09_007
crossref_primary_10_1016_j_clnu_2020_04_043
crossref_primary_10_1016_j_nut_2019_06_020
crossref_primary_10_1111_1759_7714_12855
crossref_primary_10_1016_j_urology_2024_06_030
crossref_primary_10_1007_s00423_021_02092_1
crossref_primary_10_1016_j_archger_2025_105837
crossref_primary_10_1016_j_ejso_2016_11_015
crossref_primary_10_1007_s00268_017_3999_2
crossref_primary_10_1016_j_critrevonc_2023_103965
crossref_primary_10_47717_turkjsurg_2025_6744
crossref_primary_10_1245_s10434_021_10317_2
crossref_primary_10_1007_s00595_016_1357_x
crossref_primary_10_1055_a_2460_6298
crossref_primary_10_1007_s11605_015_2835_y
crossref_primary_10_1634_theoncologist_2016_0066
crossref_primary_10_1016_j_nut_2022_111687
crossref_primary_10_1055_a_1589_7568
crossref_primary_10_1007_s00268_018_4861_x
crossref_primary_10_1016_j_acra_2023_11_040
crossref_primary_10_1111_ans_15431
crossref_primary_10_1007_s00432_024_05975_0
crossref_primary_10_1177_00031348241241713
crossref_primary_10_1093_jjco_hyaa248
crossref_primary_10_1016_j_asjsur_2024_02_004
crossref_primary_10_1245_s10434_022_11509_0
crossref_primary_10_1002_jhbp_835
crossref_primary_10_1016_j_hpb_2018_06_1803
crossref_primary_10_1016_j_oraloncology_2017_05_012
crossref_primary_10_1007_s00464_022_09416_2
crossref_primary_10_1016_j_amjsurg_2018_11_016
crossref_primary_10_3748_wjg_v30_i13_1836
crossref_primary_10_1016_j_hpb_2020_04_004
crossref_primary_10_1155_2022_8350527
crossref_primary_10_1177_000313481908500425
crossref_primary_10_1016_j_ejso_2024_108580
crossref_primary_10_1016_j_clinre_2024_102332
crossref_primary_10_1016_j_ejso_2025_110437
crossref_primary_10_1016_j_jhep_2018_06_024
crossref_primary_10_1017_S002966511500419X
crossref_primary_10_1007_s13304_021_01175_4
crossref_primary_10_3389_fonc_2020_596691
crossref_primary_10_1186_s12876_025_04176_4
crossref_primary_10_1007_s00261_024_04439_w
crossref_primary_10_1097_TP_0000000000001413
crossref_primary_10_1159_000531797
crossref_primary_10_1016_j_hpb_2016_11_009
crossref_primary_10_1245_s10434_017_6269_5
crossref_primary_10_1016_j_gassur_2024_09_002
crossref_primary_10_1007_s00595_021_02346_x
crossref_primary_10_1002_jso_23976
crossref_primary_10_1016_j_ijsu_2022_106842
crossref_primary_10_1016_j_arr_2023_102057
crossref_primary_10_1111_ggi_13320
crossref_primary_10_1186_s40001_022_00760_6
crossref_primary_10_1007_s00268_017_4255_5
crossref_primary_10_1136_bmjopen_2023_083228
crossref_primary_10_1245_s10434_020_09143_9
crossref_primary_10_3389_fnut_2024_1292834
crossref_primary_10_1016_j_jgo_2018_01_003
crossref_primary_10_3390_diagnostics13050968
crossref_primary_10_1016_j_hpb_2023_08_012
crossref_primary_10_1007_s00268_016_3504_3
crossref_primary_10_1017_S0029665120007855
crossref_primary_10_1016_j_surg_2015_08_047
crossref_primary_10_1016_j_ejso_2024_108246
crossref_primary_10_1016_j_transproceed_2023_12_008
crossref_primary_10_1111_cts_12940
crossref_primary_10_1055_a_2026_1240
crossref_primary_10_1007_s00432_016_2230_4
crossref_primary_10_1002_cam4_6030
crossref_primary_10_1245_s10434_017_6020_2
crossref_primary_10_1159_000493586
crossref_primary_10_1016_j_ejso_2016_09_006
crossref_primary_10_3892_ol_2023_13869
crossref_primary_10_1007_s00535_020_01711_w
crossref_primary_10_1016_j_surge_2017_06_001
crossref_primary_10_1016_j_clcc_2022_10_001
crossref_primary_10_1017_S0029665118000046
crossref_primary_10_1111_codi_14558
crossref_primary_10_1016_j_ejso_2018_09_030
crossref_primary_10_1097_MD_0000000000023363
crossref_primary_10_1093_jjco_hyaa218
crossref_primary_10_1016_j_clnesp_2022_04_009
crossref_primary_10_1097_SLA_0000000000001048
crossref_primary_10_3390_cancers14010261
crossref_primary_10_3390_jcm8101672
crossref_primary_10_1007_s00464_020_08041_1
crossref_primary_10_1245_s10434_017_6077_y
crossref_primary_10_1093_ibd_izy212
crossref_primary_10_1002_jpen_1171
crossref_primary_10_1016_j_dld_2021_10_010
crossref_primary_10_1186_s12885_022_09823_7
crossref_primary_10_3389_fnut_2023_1040297
crossref_primary_10_1159_000502125
crossref_primary_10_3390_cancers15225391
crossref_primary_10_3389_fnut_2023_1233973
crossref_primary_10_4240_wjgs_v16_i6_1857
crossref_primary_10_1002_jcsm_12431
crossref_primary_10_1080_01635581_2022_2159046
crossref_primary_10_1093_jjco_hyac087
crossref_primary_10_3390_gidisord3010006
crossref_primary_10_3350_cmh_2020_0192
crossref_primary_10_1002_jcsm_13759
crossref_primary_10_1631_jzus_B2300363
crossref_primary_10_1016_j_jss_2016_12_002
crossref_primary_10_1093_ndt_gfy108
crossref_primary_10_1111_hepr_13667
crossref_primary_10_1308_rcsann_2021_0082
crossref_primary_10_14235_bas_galenos_2022_87894
crossref_primary_10_1002_jhbp_236
crossref_primary_10_1016_j_clnesp_2022_10_003
crossref_primary_10_1245_s10434_019_07188_z
crossref_primary_10_1016_j_jvs_2017_06_085
crossref_primary_10_1016_j_clnu_2017_07_010
crossref_primary_10_1245_s10434_014_4281_6
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1097/SLA.0000000000000743
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
EISSN 1528-1140
ExternalDocumentID 24950264
Genre Journal Article
GroupedDBID ---
.-D
.3C
.55
.GJ
.XZ
.Z2
01R
0R~
1J1
23M
2WC
354
3O-
40H
4Q1
4Q2
4Q3
53G
5GY
5VS
6J9
71W
77Y
7O~
AAAAV
AAAXR
AAEJM
AAFWJ
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AASXQ
AAUEB
AAXQO
ABASU
ABBUW
ABDIG
ABJNI
ABOCM
ABPMR
ABPPZ
ABPXF
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACCJW
ACDDN
ACDOF
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACOAL
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEBDS
AEETU
AENEX
AFBFQ
AFCHL
AFDTB
AFEXH
AFMBP
AFNMH
AFSOK
AFUWQ
AGINI
AHJKT
AHOMT
AHQNM
AHQVU
AHRYX
AHVBC
AI.
AIJEX
AINUH
AJCLO
AJIOK
AJJEV
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
ASPBG
AVWKF
AZFZN
BAWUL
BOYCO
BQLVK
BS7
BYPQX
C45
CGR
CS3
CUY
CVF
DIK
DIWNM
DUNZO
E.X
E3Z
EBS
ECM
EEVPB
EIF
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FEDTE
FL-
FW0
GNXGY
GQDEL
H0~
HLJTE
HVGLF
HZ~
IH2
IKREB
IKYAY
IN~
IPNFZ
J5H
JF7
JF9
JG8
JK3
JK8
K-A
K-F
K8S
KD2
KMI
L-C
L7B
M18
N4W
N9A
NPM
N~7
N~B
N~M
O9-
OAG
OAH
OBH
OCB
OCUKA
ODA
ODMTH
OGEVE
OHH
OHYEH
OK1
OL1
OLB
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
R58
RIG
RLZ
RPM
RXW
S4R
S4S
T8P
TAF
TEORI
TR2
TSPGW
UQX
V2I
VH1
VVN
W3M
WH7
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YOC
ZFV
ZGI
ZXP
ZY1
ZZMQN
~H1
7X8
ADKSD
ADSXY
ID FETCH-LOGICAL-c373t-be3357ae76a8d6f2cb726a8e23a7524f455de7b1830775865711db19409b2b4a2
IEDL.DBID 7X8
ISICitedReferencesCount 326
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000369611600049&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1528-1140
IngestDate Mon Sep 08 13:30:43 EDT 2025
Mon Jul 21 05:27:51 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c373t-be3357ae76a8d6f2cb726a8e23a7524f455de7b1830775865711db19409b2b4a2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 24950264
PQID 1706206253
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1706206253
pubmed_primary_24950264
PublicationCentury 2000
PublicationDate 2015-Jun
20150601
PublicationDateYYYYMMDD 2015-06-01
PublicationDate_xml – month: 06
  year: 2015
  text: 2015-Jun
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Annals of surgery
PublicationTitleAlternate Ann Surg
PublicationYear 2015
SSID ssj0014807
Score 2.6090262
Snippet To evaluate the prevalence of sarcopenia among European patients with resectable hepatocellular carcinoma (HCC) and to assess its prognostic impact on overall...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1173
SubjectTerms Aged
Carcinoma, Hepatocellular - epidemiology
Carcinoma, Hepatocellular - surgery
Comorbidity
Disease-Free Survival
Female
Hepatectomy - mortality
Humans
Liver Neoplasms - epidemiology
Liver Neoplasms - surgery
Male
Middle Aged
Neoplasm Recurrence, Local - epidemiology
Patient Selection
Prevalence
Prognosis
Retrospective Studies
Sarcopenia - diagnostic imaging
Sarcopenia - epidemiology
Survival Analysis
Tomography, X-Ray Computed
Treatment Outcome
Title Sarcopenia Impacts on Short- and Long-term Results of Hepatectomy for Hepatocellular Carcinoma
URI https://www.ncbi.nlm.nih.gov/pubmed/24950264
https://www.proquest.com/docview/1706206253
Volume 261
WOSCitedRecordID wos000369611600049&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA7qfPDFC97mjQi-hq1NsqRPMoZjwhzDKezJ0qSJDlwz7Sb47z3phT0JgqWUlhIIp6fnfOeO0I2WGhS3DUgAYJ6w1LSJUpEhOlAqkMpGXBaFwkMxGsnpNBpXDre8SqusZWIhqFOnvY-85du8hHByerv4IH5qlI-uViM0NlGDApTxKV1iuo4iVOXSoKLAUgJLoi6di0RrMuyWrQvrQ_i6nd9AZqFs-nv_3eY-2q1gJu6WfHGANkx2iF4mwNV-XNYswfdFdWSOXYYnbwDBCU6yFA9d9kq8sMaPJl-9-_cWD0Bj-VCDm39jgLjls_Mef5_Cint-GlHm5skReu7fPfUGpJqvQDQVdEmUoZSLxIhOItOODbUSIdyakCaCh8wyzlMj4JNR3ydPdrgIglQFEZiEKlQsCY_RVuYyc4pwyq2ERVIDyZlkNpJK2LayNtVStZloouuaXDHwr99ikhm3yuM1wZropKR5vCgbbcR-LjbYiOzsD6vP0Q5gGV5mcV2ghoW_11yibf21nOWfVwVjwHU0fvgBjAbB-g
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sarcopenia+Impacts+on+Short-+and+Long-term+Results+of+Hepatectomy+for+Hepatocellular+Carcinoma&rft.jtitle=Annals+of+surgery&rft.au=Voron%2C+Thibault&rft.au=Tselikas%2C+Lambros&rft.au=Pietrasz%2C+Daniel&rft.au=Pigneur%2C+Frederic&rft.date=2015-06-01&rft.eissn=1528-1140&rft.volume=261&rft.issue=6&rft.spage=1173&rft_id=info:doi/10.1097%2FSLA.0000000000000743&rft_id=info%3Apmid%2F24950264&rft_id=info%3Apmid%2F24950264&rft.externalDocID=24950264
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1528-1140&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1528-1140&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1528-1140&client=summon